share_log

艾德生物:上海市锦天城律师事务所关于公司2023年限制性股票激励计划首次授予部分限制性股票第一个解除限售期解除限售条件成就及回购注销部分限制性股票相关事项的法律意见书

Ed Biotech: Legal Opinion of Shanghai AllBright Law Firm on the Company\'s 2023 Restricted Stock Incentive Plan for the First Time Granting of Some Restricted Stocks, the First Release of the Sales Restriction Period, Achievements of the Conditions of Cancellation of Sales Restrictions, and Matters Related to the Repurchase and Cancellation of Some Restricted Shares

SZSI ·  Nov 18
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more